Speaker illustration

undefined undefined undefined

Glucose lowering drugs or strategies, major adverse cardiovascular events and heart failure outcomes, and association with weight loss - meta-analysis of large cardiovascular outcome trials

Event: ESC Congress 2019

Topic: Diabetes and the Heart

Session: Progress in secondary prevention - New treatments

Thumbnail

ESC 365 is supported by